GlassScriptPhysician profile
Jagdesh Kandala
NPI 1265515662
$1,319.97
in general payments reported to CMS, 2019-2025
16 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.47 · 2020: $15.48 · 2021: $69.30 · 2022: $310 · 2023: $195 · 2024: $166 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $397.47 | 2022-2025 | Symplicity G3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.38 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $146.79 | 2023-2024 | Rotapro, Wolverine Coronary Cutting Balloon, Watchman Access System |
| Penumbra, INC. | $102.54 | 2025 | Indigo System |
| Recor Medical INC | $97.62 | 2025 | Paradise Ultrasound Renal Denervation System |
| Novartis Pharmaceuticals Corporation | $63.01 | 2019-2025 | |
| Abiomed | $54.77 | 2020-2021 | |
| Edwards Lifesciences Corporation | $47.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $47.04 | 2022-2024 | Xarelto |
| Amgen INC. | $34.58 | 2023-2024 | Repatha |
| Acist Medical Systems, INC. | $27.11 | 2019 | |
| Cardiva Medical, INC. | $24.01 | 2024 | Optowire |
| Cordis US Corp. | $18.10 | 2022 | |
| Merck Sharp & Dohme LLC | $17.80 | 2023 | Verquvo |
| Pfizer INC. | $15.08 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagdesh Kandala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.